Clinical Trial Update: Cardiovascular Diagnostic in Assessment of Risk HDS and HCT in Patients With Haemoblasts. [NA]

View source ↗

Summary

A clinical trial evaluating a cardiovascular diagnostic for assessing risk of cardiotoxicity in patients with haemoblasts has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiotoxicity

Snippet

Sponsor: I.M. Sechenov First Moscow State Medical University | Conditions: Cardiotoxicity | NA | Status: COMPLETED